Flmodafinil: legal
This page summarises flmodafinil's status in the places checked; it is not legal advice, and it does not cover every country or state.
United States
Flmodafinil, also catalogued as CRL-40940 and lauflumide, does not appear by name in the federal controlled-substance schedules, read on 2026-11-19. Modafinil, the compound it is a bis-fluorinated version of, does: Schedule IV lists “Modafinil 1680”.[1]
The federal Analogue Act does not reach it through modafinil. Its definition of a controlled substance analogue covers a substance “the chemical structure of which is substantially similar to the chemical structure of a controlled substance in schedule I or II”, and modafinil is in Schedule IV.[2] Not being federally scheduled is not the same as being legal to sell for consumption, and state law was not checked for this page. Flmodafinil is not an approved medicine in the United States.
Sport
The World Anti-Doping Agency's list, which states “This List shall come into effect on 1 January 2026.”, names it with its chemical name, “Flmodafinil (2-[Bis(4-fluorophenyl) methylsulfinyl]acetamide)”.[3] It sits under “S6.A: NON-SPECIFIED STIMULANTS”, in a class marked “PROHIBITED IN-COMPETITION”.[3] The list explains the category: “All prohibited substances in this class are Specified Substances except those in S6.A, which are non-Specified Substances.”[3] Fladrafinil, its N-hydroxy relative, is listed beside it.
References
- 21 CFR 1308.14, Schedule IV (eCFR, current as read 2026-11-19) — US Drug Enforcement Administration, via eCFR (National Archives)
- 21 U.S. Code § 802, Definitions (paragraph 32, controlled substance analogue) — Legal Information Institute, Cornell Law School
- World Anti-Doping Code International Standard: Prohibited List 2026, Wayback capture of 19 November 2026 — World Anti-Doping Agency
Comments
Sign in to join the conversation.
No comments yet.